Cannabinoids DEA Policy Topical 
The Cannigma
JUNE 14, 2021
All that is about to change, thanks to a change at the DEA , which cultivators and industry experts say will be monumental for cannabis research, medical marijuana patients, and potentially the broader legal status of the plant itself. “We Unfortunately, this change in policy has been promised for years and never actually materialized.”.
SpeedWeed
JUNE 8, 2021
Drug Enforcement Administration (DEA) ruled that Delta-8 THC, a cannabinoid that occurs naturally and can also be processed from CBD, is a controlled substance not protected by the 2018 Farm Bill, which legalized hemp agriculture and products derived from the crop. Last year, the U.S. View original article.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
United Patients Group
JANUARY 15, 2023
THC is the chemical aka cannabinoid in cannabis that gives off the psychoactive feeling. THC is known to interact with the cannabinoid 1 (CB1) receptors in the brain, eliciting a feeling of euphoria and a sense of being high. However, the DEA and FDA still consider CBD a drug regulated under the Schedule I classification.
Project CBD
AUGUST 23, 2023
Earlier this year, the Food & Drug Administration disclosed that it would not regulate non-pharmaceutical CBD products, thereby putting the onus on Congress to devise an appropriate regulatory framework for cannabidiol and other hemp-derived cannabinoids. percent on a dry weight basis.”
Veriheal
JULY 29, 2021
Following the recent news of Texan sprinter Sha’Carri Richardson returning a positive test for cannabis, a debate has erupted on the topic of cannabis as a performance-enhancing drug – can the plant enhance agility, strength, and/or speed? Fast forward to 2019 and the DEA unveiled eagerly anticipated plans for cannabis research.
Cannabis Law Report
SEPTEMBER 23, 2019
Marijuana and Cannabinoids: Health, Research and Regulatory Considerations (Position Paper). 1 Simultaneously, the AAFP acknowledges preliminary evidence indicates marijuana and cannabinoids may have potential therapeutic benefits, while also recognizing subsequent negative public health and health outcomes associated with cannabis use.
Cannabis Law Report
AUGUST 12, 2022
Drug policy topics have become a consistent feature of the Austin-based event in recent years as more states have legalized cannabis and moved to reform laws around psychedelics like psilocybin locally and at the state level. Mainstreaming Cannabinoids – Path To Legalization. Obtaining DEA License to Grow Psilocybin Mushrooms.
Expert insights. Personalized for you.
133 
Let's personalize your content